Larchmont, NJ, United States of America

Michael Sasha John

This inventor holds 6 USPTO granted patents. Top assignee: Avertix Medical, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Sasha John. Retrieved from https://idiyas.com/inventor/michael-sasha-john-j47olls0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 1


Location History:

  • Larchmont, NJ (US) (2023)
  • Long Branch, NJ (US) (2024)

Company Filing History:


Years Active: 2023-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Michael Sasha John: Innovator in Neurostimulation Technology

Introduction

Michael Sasha John is a prominent inventor based in Larchmont, NJ (US), known for his significant contributions to the field of neurostimulation. With a total of four patents to his name, he has made remarkable advancements in medical technology aimed at improving patient care.

Latest Patents

One of his latest patents is a neurostimulation system with linked programming adjustment. This innovative system features an implanted neurostimulator equipped with a processor that controls stimulation parameter values. It creates stimulation signals applied to a patient's body, maintaining relative proportional amplitudes of a set of linked stimulation signals during stimulation according to a specific protocol. An external programmer receives user input data, allowing for adjustments to the stimulation protocol. The system includes independently operable electrode contacts that are electrically coupled to the neurostimulator, with at least two subsets of electrode contacts linked to receive the stimulation signals. Additionally, an information transmission system with telemetry circuitry transmits the stimulation signal values in accordance with the protocol.

Another notable patent involves neurostimulation treatment for abnormal connectivity with a cingulate region. This method guides targeted neurostimulation to a patient's brain by sensing neuroimaging data. A processor evaluates this data to calculate results for a modeled functional measure of a specific brain network, defining a first and second brain region. A target location is determined in the first brain region based on the result data and a functional connection measure between the two regions. A transcranial magnetic stimulator is then adjusted to provide a magnetic stimulation signal for the target location.

Career Highlights

Michael Sasha John is currently associated with Avertix Medical, Inc., where he continues to develop innovative solutions in neurostimulation technology. His work has significantly impacted the medical field, particularly in treating neurological conditions.

Collaborations

Throughout his career, Michael has collaborated with notable professionals, including David R. Fischell and David Keenan. These collaborations have further enhanced the development of his innovative technologies.

Conclusion

Michael Sasha John is a key figure in the advancement of neurostimulation technology, with multiple patents that reflect his dedication to improving patient outcomes. His work at Avertix Medical, Inc. and collaborations with esteemed colleagues underscore his commitment to innovation in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…